Utilizing Senior Companions to Enhance Dementia Care
Alzheimer Disease · Dementia
Bottom Line
View on ClinicalTrials.gov: NCT03667924 ↗Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PorchLight Project (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- University of Minnesota
- Primary completion
- Aug 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Utilization of LTSS by PWML and Caregivers |
1; 1; 2; 1; 3; 2 | — |
| PRIMARY Quality of Primary Care Interactions |
2.92; 3.22; 3.50 | — |
| PRIMARY Caregiver Distress: Burden |
20.5; 30.33; 13.00 | — |
| PRIMARY Caregiver Distress: Depressive Symptoms |
1.29; 1.22; 1.17 | — |
| PRIMARY PWML Well-being |
60.71; 53.83; 52.00 | — |
| PRIMARY PWML Depression |
4.00; 3.83; 5.00 | — |
| PRIMARY PWML Quality of Life |
34.86; 34.67; 37.20 | — |
| SECONDARY Caregiver Self-efficacy |
32.00; 28.33; 31.67 | — |
Summary
Eligibility Criteria
Inclusion criterion for the Senior Companion: 1) be a current volunteer through LSS-MN 2) be willing to complete the CARES® modules and 4-part training session provided by UMN research staff and 3) be 21 years of age or older.
Inclusion criteria for the PWML will be based on one of the following scenarios: 1) the person or their caregiver are concerned about the person's memory loss, 2) the person has a physician diagnosis of ADRD, 3) the caregiver (or PWML) scores 2 or greater on the AD8. The PWML must be 55 years of age or older.
Inclusion criteria for the caregiver is that the individual is 1) 21 years of age or older, 2) self-identifies as someone who provides help to the PWML because of their cognitive impairments, and 3) the care recipient is eligible for the study as per the above criteria.
Exclusion Criteria
A PWML or caregiver will be ineligible if they have a diagnosis of a serious psychiatric illness, their symptoms have worsened in the last 6 months, and they don't receive steady, ongoing treatment for those symptoms.
Data sourced from ClinicalTrials.gov (NCT03667924). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.